Endurance Wealth Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$0 Hold
10
﹤0.01% 652
2023
Q1
$0 Hold
10
﹤0.01% 655
2022
Q4
$0 Hold
10
﹤0.01% 650
2022
Q3
$0 Hold
10
﹤0.01% 631
2022
Q2
$1K Hold
10
﹤0.01% 611
2022
Q1
$1K Hold
10
﹤0.01% 628
2021
Q4
$1K Hold
10
﹤0.01% 614
2021
Q3
$2K Buy
+10
New +$2.2K ﹤0.01% 607

Other funds holding NVAX

Endurance Wealth Management's NVAX Position: Q2 2023 in Review

Endurance Wealth Management held its Novavax (NVAX) position steady in Q2 2023 at 10 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #652.

Endurance Wealth Management first reported a position in NVAX in Q3 2021 and has held it in 8 quarters since. The position peaked at $2K in Q3 2021. 215 funds tracked by Wall St. Rank hold NVAX as of Q2 2023.

  • Endurance Wealth Management held 10 shares of Novavax worth $0 as of Q2 2023.
  • Endurance Wealth Management left its Novavax share count unchanged in Q2 2023.
  • Novavax made up ﹤0.01% of Endurance Wealth Management's portfolio in Q2 2023, its #652 holding.
  • Endurance Wealth Management first reported a position in Novavax in Q3 2021 and has held it in 8 quarters since.
  • Endurance Wealth Management's Novavax position peaked at $2K in Q3 2021.
  • 215 funds tracked by Wall St. Rank held Novavax as of Q2 2023.

Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.